ARM Innovation Hub
Cambridgeand mid banner advertisement
Advertisement: partnersand mid banner
Advertisement: HCR Hewitsons mid banner
Advertisement: CJBS mid banner
Advertisement: Excalibur Healthcare mid banner
Barr Ellison Solicitors – commercial property
Advertisement mid banner S-Tech 1
Advertisement: Simpsons Creative mid banner
Advertisement: RSM mid banner
Advertisement: SATAVIA mid banner
Advertisement: Cambridge Network mid banner
Mid banner advertisement: BDO
Advertisement: Bar Ellison mid banner property
Advertisement: Kao Data Centre mid banner
Advertisement: Mogrify mid banner
Advertisement: Birketts mid banner
Advertisement: EBCam mid banner
7 February, 2006 - 15:26 By Staff Reporter

Eisai does it with new European HQ in Hertfordshire

A third Japanese technology giant has confirmed a move into the East of England and could create hundreds of new jobs. And a fourth – possibly the biggest of all – is thought to be on its way.A third Japanese technology giant has confirmed a move into the East of England and could create hundreds of new jobs. And a fourth – possibly the biggest of all – is thought to be on its way.

Eisai, one of the top 20 pharmaceutical companies in the world, has announced that it is to locate its European corporate headquarters and manufacturing centre in Hatfield, Hertfordshire.

As part of its global strategy, the Japanese company is to build a state-of-the-art facility on the Hatfield Business Park, scheduled for commissioning during 2008.

David Marlow, chief executive of EEDA said: “The decision by EISAI to open its headquarters in Hertfordshire is a significant achievement for the East of England.

“The hundreds of jobs that will be created will have a significant impact on the local economy and on the future prosperity of the region.”

East of England International, the official international business support agency for the region, worked closely with UK Trade & Investment (UKTI) to secure the investment.

EEI provided in-depth data on the UK’s pharmaceutical and research base, together with current research interests and key contacts.

Property profiles to meet the company’s brief were produced and site visits conducted with Eisai representatives.

A comprehensive analysis of the region’s skills base, with its high proportion of scientists, engineers, technologists and technicians was also compiled.

The announcement underlines Eisai’s recognition of the region’s outstanding pharmaceutical and biotech strengths, both in research and manufacturing.

By locating in Hertford-shire, Eisai will be at the heart of Europe’s leading life sciences cluster, which includes such international centres of excellence as the Babraham Institute and The Sanger Centre, represented by networking organisations such as the Eastern Region Biotech-nology Initiative (ERBI).

James Gray, chief executive of East of England International said: “We are committed to providing ongoing support to ensure Eisai’s new UK investment is a huge success.

“The East of England offers an unrivalled range of benefits for Eisai: a supportive environment for innovation and entrepreneurship, an excellent pool of highly skilled sector professionals and proximity to global players in the sector already located here.”

George Kieffer, who is chairman, East of England International added: “The East of England leads the UK in global research and development, particularly in pharmaceuticals.”

The East of England has the UK’s highest regional expenditure in R&D and largest per capita concentration of R&D engineers.

As exclusively revealed in Business Weekly’s January 12 edition, Hitachi Software Group and Japanese games publisher D3Publishing have already moved into Cambridge and an electronics giant is committed to moving to Cambridge but has declined publicity for the time being.

Add new comment

Newsletter Subscription

Stay informed of the latest news and features